Delivery Order SPE2DB24D2101-SPE2DB25FKMST
- Not listed
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $6,976.65 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order worth $2,197.41 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently...
- This is a $13,953.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award is not associated with a set-aside program and has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a Firm Fixed Price pricing type and a ceiling value of $4,651.10, with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $4,651.10 and a completion date of July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $4,394.82 firm fixed-price contract has a completion date of September 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LEQVIO 284 MG/1.5 ML syringes. This $4,394.82 delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support the Department of Defense. The contract has an...
- The Defense Logistics Agency Troop Support Medical awarded a $13,018.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562313798 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 26, 2023 through October 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a ceiling value of $9,302.20 and a performance period through March 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. This contract is part of a larger...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMSTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,976.65 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, competitively awarded contract—with no set-aside designation—calls for delivery of the pharmaceutical product to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. LEQVIO is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular disease, and this order represents a routine medical supply procurement supporting federal healthcare systems, including the Defense Health Agency and military medical programs. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to serve as a comprehensive global pharmaceutical supplier to military healthcare operations worldwide, covering a broad range of brand-name and generic medications, vaccines, syringes, and specialized medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen maintains significant capacity to fulfill the Defense Department's medical supply chain requirements through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 7/24/25 |